2023-07-19T00:51:11Z
ENA-FIRST-PUBLIC
2023-07-19T00:51:11Z
ENA-LAST-UPDATE
GSM6732475
External Id
SAMN31740223
External Id
2023-07-19T00:51:11Z
INSDC first public
2023-07-19T00:51:11Z
INSDC last update
public
INSDC status
SRS15765590
SRA accession
GSM6732475
Submitter Id
NCBI
broker name
Expanded TIL
cell line
CD4+CD8+
cell type
missing
collection_date
human
common name
female
gender
missing
geo_loc_name
53%
infusion percent_cd4
44%
infusion percent_cd8
3.35E+10
number til_infused
Homo sapiens
organism
9
overall survival_months
1
pfs censor_at_12_months
4
pfs months
PD
response
Homo sapiens
scientific_name
TIL ACT Product
source_name
1
survival censor
TIL ACT Product
tissue
Patient 18 CD4+CD8+ [Pt18_DP RNA-seq]
title
TIL ACT
treatment
17057
trial